Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Austedo improving decision making drug discovery?Patente xarelto 2026?Atezolizumab loss of exclusivity?Rinvoq medication patent?Cyclopentolate hydrochloride?
See the DrugPatentWatch profile for entresto
Entresto (sacubitril/valsartan) is not listed as a widely available, routinely marketed brand in Russia based on the information provided here. I can’t confirm Russian retail availability without additional source details (for example, a Russian pharmacy listing, distributor announcement, or an official regulator/market-authorization record).
Even when a drug is globally approved, availability in a specific country can depend on: - local marketing/registration status in that market - supply routes and import restrictions - reimbursement/health-system purchasing decisions - licensing and distribution agreements that can change over time
If you’re trying to verify current availability, the most reliable checks are: - a current listing on major Russian pharmacy websites - the Russian regulator’s drug registry for the brand name (and/or generic sacubitril/valsartan) - recent import/distributor announcements for Entresto - whether the drug is being sold as a branded product versus only via specific channels If you tell me whether you mean “can I buy it at a pharmacy” or “is it approved/registered in Russia,” I can tailor the answer to that exact scenario.
Other Questions About Entresto :